Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A collaborative study, which includes contributions from NDORMS researchers Aaron Crowther and supervisor Dario Carugo, explores new ways to model bladder biology and infection, allowing evaluation of antimicrobial therapies under physiologically relevant conditions.

Bacteria on P-FLO Organoid under Flow Conditions
Microscopy image of bacterial cells after exposure to flow (using the P-FLO device) on the bladder microtissue model

Urinary tract infections (UTIs) remain a major global health challenge, with high recurrence rates and growing antimicrobial resistance contributing to an estimated 260,000 deaths annually. Current laboratory susceptibility tests often fail to predict real-world treatment outcomes, underscoring the need for physiologically relevant infection models.

A recent study led by Beyond Antibiotics researcher, Dr Ramon Garcia Maset, in collaboration with Dr Aaron Crowther, Postdoctoral Research Assistant in Antimicrobial Interventions at NDORMS and Mr Davide De Grandi, who were co-supervised by Prof Jennifer Rohn at University College London and Dr Dario Carugo, Associate Professor of Biostimulation and Immunological Engineering at the Botnar Institute, deploys innovative models as platforms to better replicate the bladder environment:

  • 3D-UHU – a three-dimensional urothelial microtissue model
  • P-FLO – a novel mesofluidic system incorporating realistic flow dynamics

The team showed that microenvironmental complexity and mechanical forces significantly influenced the behaviour of uropathogenic E. coli and the effectiveness of antibiotics and bacteriophages. While nitrofurantoin showed strong activity in standard assays, it was less effective in advanced models. Similarly, bacteriophage therapy and combination treatments demonstrated variable performance depending on physiological conditions and flow dynamics.

Implications for Antimicrobial Resistance:

  • Conventional testing may overestimate drug efficacy, risking treatment failure (and consequently, antibiotic prescriptions that don't work as intended, necessitating further treatments down the road)
  • Physiologically informed models are essential to design therapies that work in real infection environments
  • Understanding host-pathogen interactions under realistic conditions can guide treatment strategies beyond traditional antibiotics or help maintain the effectiveness of existing antibiotics

The fluidic device design and image analysis pipeline developed in the study have been made open access for adoption by other researchers.

Read the pre-print: Effect of human urinary microenvironment and fluid flow on antibiotic and phage therapy efficacy against uropathogenic Escherichia coli | bioRxiv

This research is funded by the Engineering and Physical Science Research Council (EPSRC) Programme Grant Scheme.

 

Similar stories

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.

Ghada Alsaleh awarded an Arthritis UK Bridging Fellowship

Professor Ghada Alsaleh has been awarded an Arthritis UK Bridging Fellowship to advance her work studying potential osteoarthritis (OA) treatments.